← Leaderboards
Louis B Hersh
University Of Kentucky
$18,487,866
Attributed
$19,315,789
Total exposure
19
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–22$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$41,532,709 · 21
By mechanism
P20$24,259,789 · 10
P30$7,719,748 · 3
R01$7,390,161 · 4
T32$1,263,190 · 1
R21$645,206 · 2
P50$254,615 · 1
Top collaborators
- David W Rodgers5 shared
Most similar at University Of Kentucky
Same institution · by research overlap
- Daret K St Clair$20,807,410
- Avindra Nath$17,882,997
- Stephen W Scheff$7,594,722
- Kathryn M Thrailkill$1,641,998
- Mark P Mattson$1,922,482
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseProgramsHuman DiseaseMentorsCenters Of Research ExcellenceMolecularGrantFacultyEnzyme ActivityPeptidesNeprilysinPeptide HydrolasesCore FacilityResourcesEnzymesResearch PersonnelDiabetes MellitusDesignFundingSuccessExtramural ActivitiesInstitutionUnited States National Institutes Of HealthUniversities
Grant awards (70)
Insulin Degrading Enzyme: Physiological Function and its Spatial and Activity Modulation$411,769
R01 · FY2022 · GM · contact PI
Insulin Degrading Enzyme: Physiological Function and its Spatial and Activity Modulation$411,769
R01 · FY2021 · GM · contact PI
Insulin Degrading Enzyme: Physiological Function and its Spatial and Activity Modulation$411,769
R01 · FY2020 · GM · contact PI
Insulin Degrading Enzyme: Physiological Function and its Spatial and Activity Modulation$8,770
R01 · FY2020 · GM · contact PI
Insulin Degrading Enzyme: Physiological Function and its Spatial and Activity Modulation$411,769
R01 · FY2019 · GM · contact PI
COBRE for the Center for Molecular Medicine$1,012,262
P30 · FY2018 · GM · contact PI
Administrative Core$332,780
P30 · FY2018 · GM · contact PI
COBRE for the Center for Molecular Medicine$1,128,750
P30 · FY2017 · GM · contact PI
Administrative Core$356,544
P30 · FY2017 · GM · contact PI
COBRE for the Center for Molecular Medicine$1,128,750
P30 · FY2016 · GM · contact PI
Administrative Core$371,073
P30 · FY2016 · GM · contact PI
Project-001$197,878
P30 · FY2016 · GM · contact PI
COBRE for the Center for Molecular Medicine$197,878
P30 · FY2016 · GM · contact PI
COBRE for the Center for Molecular Medicine$1,128,125
P30 · FY2015 · GM · contact PI
Administrative Core$370,868
P30 · FY2015 · GM · contact PI
COBRE for the Center for Molecular Medicine$1,125,000
P30 · FY2014 · GM · contact PI
Administrative Core$369,840
P30 · FY2014 · GM · contact PI
Center for Biomedical Research Excellence in the Molecular Basis of Human Disease$2,073,795
P20 · FY2013 · GM · contact PI
Center for Biomedical Research Excellence in the Molecular Basis of Human Disease$2,149,009
P20 · FY2012 · GM · contact PI
Center for Biomedical Research Excellence in the Molecular Basis of Human Disease$2,149,009
P20 · FY2011 · RR · contact PI
ADMINISTRATIVE CORE$719,123
P20 · FY2011 · RR · contact PI
Degradation of Opioid Peptides$281,778
R01 · FY2011 · DA · contact PI
Center for Biomedical Research Excellence in the Molecular Basis of Human Disease$2,170,717
P20 · FY2010 · RR · contact PI
ADMINISTRATIVE CORE$467,247
P20 · FY2010 · RR · contact PI
Degradation of Opioid Peptides$284,625
R01 · FY2010 · DA · contact PI
Neprilysin and Peripheral Clearance of Amyloid Peptides$184,783
R21 · FY2010 · AG · contact PI
Center for Biomedical Research Excellence in the Molecular Basis of Human Disease$1,785,490
P20 · FY2009 · RR · contact PI
Center for Biomedical Research Excellence in the Molecular Basis of Human Disease$445,313
P20 · FY2009 · RR · contact PI
Degradation of Opioid Peptides$287,499
R01 · FY2009 · DA · contact PI
KY COBRE: ADMINISTRATIVE CORE$264,752
P20 · FY2009 · RR · contact PI
Training in Drug Abuse Related Research$237,623
T32 · FY2009 · DA · contact PI
Neprilysin and Peripheral Clearance of Amyloid Peptides$166,823
R21 · FY2009 · AG · contact PI
Center of Biomedical Research Excellence in Molecular Basis of Human Disease$2,003,172
P20 · FY2008 · RR · contact PI
KY COBRE: ADMINISTRATIVE CORE$726,150
P20 · FY2008 · RR · contact PI
Degradation of Opioid Peptides$287,499
R01 · FY2008 · DA · contact PI
Estrogen, androgen, neprilysin, and amyloid peptides.$224,858
R01 · FY2008 · NS · contact PI
Training in Drug Abuse Related Research.$157,252
T32 · FY2008 · DA · contact PI
Center of Biomedical Research Excellence in Molecular Basis of Human Disease$1,990,154
P20 · FY2007 · RR · contact PI
KY COBRE: ADMINISTRATIVE CORE$326,087
P20 · FY2007 · RR · contact PI
Degradation of Opioid Peptides$293,366
R01 · FY2007 · DA · contact PI
Estrogen, androgen, neprilysin, and amyloid peptides.$224,833
R01 · FY2007 · NS · contact PI
Training in Drug Abuse Related Research.$185,151
T32 · FY2007 · DA · contact PI
COBRE Molecular Basis of Human Disease$1,995,147
P20 · FY2006 · RR · contact PI
KY COBRE: ADMINISTRATIVE CORE$325,588
P20 · FY2006 · RR · contact PI
Training in Drug Abuse Related Research.$236,845
T32 · FY2006 · DA · contact PI
Estrogen, androgen, neprilysin, and amyloid peptides.$231,390
R01 · FY2006 · NS · contact PI
Degradation of Opioid Peptides$36,575
R01 · FY2006 · DA · contact PI
COBRE Molecular Basis of Human Disease$1,986,172
P20 · FY2005 · RR
Degradation of Opioid Peptides$325,800
R01 · FY2005 · DA
KY COBRE: ADMINISTRATIVE CORE$317,688
P20 · FY2005 · RR
Estrogen, androgen, neprilysin, and amyloid peptides.$238,442
R01 · FY2005 · NS
Training in Drug Abuse Related Research.$229,932
T32 · FY2005 · DA
Use of bone marrow stem cells to treat Alz. Dis$146,300
R21 · FY2005 · AG
COBRE Molecular Basis of Human Disease$1,970,981
P20 · FY2004 · RR
KY COBRE: ADMINISTRATIVE CORE$394,195
P20 · FY2004 · RR
Degradation of Opioid Peptides$325,800
R01 · FY2004 · DA
CHOLINE ACETYLTRANSFERASE$301,197
R01 · FY2004 · AG
Training in Drug Abuse Related Research.$216,387
T32 · FY2004 · DA
Use of bone marrow stem cells to treat Alz. Dis$147,300
R21 · FY2004 · AG
Degradation of Opioid Peptides$325,800
R01 · FY2003 · DA
CHOLINE ACETYLTRANSFERASE$292,423
R01 · FY2003 · AG
Degradation of Opioid Peptides$325,800
R01 · FY2002 · DA
CHOLINE ACETYLTRANSFERASE$283,907
R01 · FY2002 · AG
CHOLINERGIC NEURONS FOR TRANSPLANTATION$0
P50 · FY2002 · AG
Degradation of Opioid Peptides$325,913
R01 · FY2001 · DA
CHOLINE ACETYLTRANSFERASE$275,667
R01 · FY2001 · AG
CHOLINERGIC NEURONS FOR TRANSPLANTATION$254,615
P50 · FY2001 · AG
CHOLINERGIC NEURONS FOR TRANSPLANTATION$0
P50 · FY2001 · AG
DEGRADATION OF OPIOID PEPTIDES$293,170
R01 · FY2000 · DA
CHOLINE ACETYLTRANSFERASE$267,973
R01 · FY2000 · AG